Newsletter Signup
SA's Nightly Scans Small Caps Large Caps Stock Tutorials Contests

Go Back   Stock Hideout > Stock Message Boards > Small Market Capitalization

» Log in
User Name:

Password:

Not a member yet?
Register Now!



RSS Feed for "GNBT"
Reply
 
LinkBack Thread Tools Display Modes
  #1 (permalink)  
Old 11-17-2008, 08:56 AM
Junior Member
 
Join Date: Oct 2008
Location: Wisconsin
Posts: 10
Default Generex Biotechnology Corp. - GNBT

Generex Biotechnology Corporation (GNBT) looks positive for gain today!

"WORCESTER, Mass. and MUMBAI, India, Nov 14, 2008 (GlobeNewswire via COMTEX) -- ( :: Generex Biotechnology Corporation ::), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, and Shreya Life Sciences Pvt. Ltd. ( www.shreya.co.in), the Company's importation, marketing and distribution licensee in India and the fourth largest marketer of insulin in India, jointly announced today the launch of commercial retail sales of Generex Oral-lyn(tm) in India. Generex Oral-lyn is approved in India for the treatment of adults and children with Type 1 and Type 2 diabetes and will be marketed and sold in India under the brand name "Oral-Recosulin"."
Reply With Quote
  #2 (permalink)  
Old 11-17-2008, 09:26 AM
Senior Member
 
Join Date: Jan 2008
Posts: 183
Default re: Generex Biotechnology Corp. - GNBT

I agree...this is one to watch

Here is the Sharpchart (there are no pinchers, I checked)

GNBT - SharpCharts from StockCharts.com

It cannot be seen here but the Bollinger Bands are like a long tight tunnel and I like the position of the share price within this formation, bouncing off the top of the 20dayMA...very nice

You can see that the share price has tracked just below its 50 dayMA and now it is headed in a way that looks like it will challenge this line in the near future.

The TRIX is arching strongly positive, the RSI is flatlined about 50% looking like it is staging for a rise too. The Accum/Dist is unchanged and negative but that does not bother me too much.

Here is the P&F chart



Firm support is at $0.32 the resistance is at $0.35...almost as though we have reached the apex of a pennant....this is a critical time for sure. That next resistance is at $0.39....This is close to the 50dayMA and break this and it is clear sailing to $0.50

Here is the 5 day Bigchart.com linechart



You can see that strong support at $0.32, can't you? The resistance at $0.35 is shown at a lesser rate. The tightened BB's in this chart shows there will be a jump/fall of significance on opening....I'd bet it will be on the upside.

Yes this is a stock to watch all right
__________________
I am not a stockbroker. I retired four years ago and learned charting. The opinions expressed in my posts are my own. Do your own DD and accept or reject my comments as you please.
Reply With Quote
  #3 (permalink)  
Old 11-17-2008, 09:31 AM
Junior Member
 
Join Date: Oct 2008
Location: Wisconsin
Posts: 10
Default re: Generex Biotechnology Corp. - GNBT

I'm new to this and starting out ok. I still have a way to go though. Thanks for the reply and vote of confidance.
Reply With Quote
  #4 (permalink)  
Old 11-19-2008, 01:21 PM
Junior Member
 
Join Date: Oct 2008
Location: Wisconsin
Posts: 10
Talking Re: Generex Biotechnology Corp. - GNBT

Generex just got awarded two patents!

WORCESTER, Mass., Nov 19, 2008 (GlobeNewswire via COMTEX) -- Generex Biotechnology Corporation (GNBT) ( :: Generex Biotechnology Corporation ::), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it has received two new patents, one in Mexico (issued by the Mexican Institute of Industrial Property), the other in New Zealand (issued by the Intellectual Property Office of New Zealand).
The patents share the title, "Pharmaceutical Compositions for Buccal Delivery of Pain Relief Medications," and contain claims to a pharmaceutical composition for pain relief containing a narcotic analgesic in micellar form.
"We are pleased that our patent portfolio is expanding to include the pain relief application," said Rose Perri, the Company's Chief Operating Officer. "As we continue the pivotal Phase III studies of our flagship product, Generex Oral-lyn(tm), we seek additional applications for our proprietary drug platform technology."
Generex currently holds an aggregate of 130 patents worldwide (21 of which are United States patents) and has an aggregate of 132 patent applications pending in various jurisdictions.
Reply With Quote
  #5 (permalink)  
Old 01-27-2009, 06:41 AM
Chart Specialist
 
Join Date: Aug 2008
Posts: 1,088
Default Re: Generex Biotechnology Corp. - GNBT

Generex Biotechnology Corp. - GNBT Chart turning upward here. Could see .39 next for resistance

__________________
All my posts are purely my opinion. Please use your own buy and sell signals and never invest in a stock you can not afford to lose money on. For a complete disclaimer click here
Reply With Quote
Reply

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On
Trackbacks are On
Pingbacks are On
Refbacks are On



All times are GMT -4. The time now is 08:58 PM.


Clicky Web Analytics